Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-01-29

AUTHORS

Shaji K. Kumar, Jesus G. Berdeja, Ruben Niesvizky, Sagar Lonial, Jacob P. Laubach, Mehdi Hamadani, A. Keith Stewart, Parameswaran Hari, Vivek Roy, Robert Vescio, Jonathan L. Kaufman, Deborah Berg, Eileen Liao, S. Vincent Rajkumar, Paul G. Richardson

ABSTRACT

Triplet combinations containing a proteasome inhibitor are a standard of care in newly diagnosed multiple myeloma (NDMM). We examined the long-term efficacy and safety of the all-oral combination of weekly ixazomib plus lenalidomide-dexamethasone (IRd), followed by single-agent ixazomib maintenance in NDMM patients. Of 65 enrolled patients, 53 received ixazomib 4 mg (days 1, 8, and 15) plus lenalidomide 25 mg (days 1-21) and dexamethasone 40 mg (days 1, 8, 15, and 22) for up to twelve 28-day induction cycles. Twenty-three patients discontinued induction for stem cell transplantation (SCT). In the remaining 42 patients, overall response rate was 80%, including 63% ≥very good partial response (VGPR) and 32% complete responses. At a median follow-up of 56 months, median progression-free survival (PFS) was 35.4 months in the total population. Twenty-five patients received ixazomib maintenance; eight deepened their response (76% ≥VGPR), and median PFS was 37.2 months in this subgroup. Nine of 42 patients who did not proceed to SCT (14% of total population) had an adverse event requiring discontinuation. Ixazomib (median ≥ 96%) and lenalidomide (median 88-94%) relative dose intensities were maintained throughout treatment. Weekly IRd, followed by ixazomib maintenance, was highly active with acceptable toxicity, enabling long-term administration with no evidence of cumulative toxicities. More... »

PAGES

1-11

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41375-019-0384-1

DOI

http://dx.doi.org/10.1038/s41375-019-0384-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111760610

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30696949


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Mayo Clinic", 
          "id": "https://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Mayo Clinic, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kumar", 
        "givenName": "Shaji K.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sarah Cannon", 
          "id": "https://www.grid.ac/institutes/grid.419513.b", 
          "name": [
            "Sarah Cannon Research Institute, Nashville, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berdeja", 
        "givenName": "Jesus G.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "NewYork\u2013Presbyterian Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413734.6", 
          "name": [
            "Myeloma Center, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Niesvizky", 
        "givenName": "Ruben", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Emory University", 
          "id": "https://www.grid.ac/institutes/grid.189967.8", 
          "name": [
            "Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lonial", 
        "givenName": "Sagar", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dana\u2013Farber Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Dana-Farber Cancer Institute, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laubach", 
        "givenName": "Jacob P.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "West Virginia University", 
          "id": "https://www.grid.ac/institutes/grid.268154.c", 
          "name": [
            "West Virginia University, Mary Babb Randolph Cancer Center, Morgantown, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hamadani", 
        "givenName": "Mehdi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic", 
          "id": "https://www.grid.ac/institutes/grid.417468.8", 
          "name": [
            "Mayo Clinic College of Medicine, Scottsdale, AZ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stewart", 
        "givenName": "A. Keith", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hari", 
        "givenName": "Parameswaran", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic", 
          "id": "https://www.grid.ac/institutes/grid.417467.7", 
          "name": [
            "Mayo Clinic, Jacksonville, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roy", 
        "givenName": "Vivek", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vescio", 
        "givenName": "Robert", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Emory University", 
          "id": "https://www.grid.ac/institutes/grid.189967.8", 
          "name": [
            "Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaufman", 
        "givenName": "Jonathan L.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Takeda (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419849.9", 
          "name": [
            "Millennium Pharmaceuticals Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berg", 
        "givenName": "Deborah", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biogen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417832.b", 
          "name": [
            "Millennium Pharmaceuticals Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA", 
            "Biogen Inc., Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liao", 
        "givenName": "Eileen", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic", 
          "id": "https://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Mayo Clinic, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rajkumar", 
        "givenName": "S. Vincent", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dana\u2013Farber Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Dana-Farber Cancer Institute, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Richardson", 
        "givenName": "Paul G.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0140-6736(16)31594-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003452470"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)61424-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008465800"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)71125-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012022447"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2007-05-090258", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012727802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-11-395749", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014156690"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bcj.2015.60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016382579", 
          "https://doi.org/10.1038/bcj.2015.60"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.48.4626", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017077030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-11-464503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019804798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-02-268862", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023108271"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.mayocp.2013.01.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023181533"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-08-373514", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026926325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-08-448563", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027118737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa030288", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028177288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.39.6820", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029641259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404284", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033553106", 
          "https://doi.org/10.1038/sj.leu.2404284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404284", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033553106", 
          "https://doi.org/10.1038/sj.leu.2404284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bcj.2016.89", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033740632", 
          "https://doi.org/10.1038/bcj.2016.89"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-04-403733", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034167280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1516282", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035239228"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.58.7618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035321177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-01-548941", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037215825"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-01-548826", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039247879"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-11-374249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040451549"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0801479", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043382081"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2015.274", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044481919", 
          "https://doi.org/10.1038/leu.2015.274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.60.2466", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045415758"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/17474086.2015.1001360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045860916"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1998.00930.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051933965"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2016-05-717769", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064123122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1611750", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084540242"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjh.14733", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085218183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/bsr20170304", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090694444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrdp.2017.46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090829304", 
          "https://doi.org/10.1038/nrdp.2017.46"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2017.170118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090917868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/jbm.s102328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091307845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2017-06-791228", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092354997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2017-07-795047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092754671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)33003-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110509482"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)33003-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110509482"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(18)33003-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110509482"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01-29", 
    "datePublishedReg": "2019-01-29", 
    "description": "Triplet combinations containing a proteasome inhibitor are a standard of care in newly diagnosed multiple myeloma (NDMM). We examined the long-term efficacy and safety of the all-oral combination of weekly ixazomib plus lenalidomide-dexamethasone (IRd), followed by single-agent ixazomib maintenance in NDMM patients. Of 65 enrolled patients, 53 received ixazomib 4\u2009mg (days 1, 8, and 15) plus lenalidomide 25\u2009mg (days 1-21) and dexamethasone 40\u2009mg (days 1, 8, 15, and 22) for up to twelve 28-day induction cycles. Twenty-three patients discontinued induction for stem cell transplantation (SCT). In the remaining 42 patients, overall response rate was 80%, including 63% \u2265very good partial response (VGPR) and 32% complete responses. At a median follow-up of 56 months, median progression-free survival (PFS) was 35.4 months in the total population. Twenty-five patients received ixazomib maintenance; eight deepened their response (76% \u2265VGPR), and median PFS was 37.2 months in this subgroup. Nine of 42 patients who did not proceed to SCT (14% of total population) had an adverse event requiring discontinuation. Ixazomib (median\u2009\u2265\u200996%) and lenalidomide (median 88-94%) relative dose intensities were maintained throughout treatment. Weekly IRd, followed by ixazomib maintenance, was highly active with acceptable toxicity, enabling long-term administration with no evidence of cumulative toxicities.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/s41375-019-0384-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1097065", 
        "issn": [
          "0887-6924", 
          "1476-5551"
        ], 
        "name": "Leukemia", 
        "type": "Periodical"
      }
    ], 
    "name": "Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance", 
    "pagination": "1-11", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "17f8a23583019643f4f75c37daa9c14411e4b50d70ed085e760755064ba59018"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30696949"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8704895"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41375-019-0384-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111760610"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41375-019-0384-1", 
      "https://app.dimensions.ai/details/publication/pub.1111760610"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T08:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000326_0000000326/records_68460_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/s41375-019-0384-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41375-019-0384-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41375-019-0384-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41375-019-0384-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41375-019-0384-1'


 

This table displays all metadata directly associated to this object as RDF triples.

295 TRIPLES      21 PREDICATES      63 URIs      18 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41375-019-0384-1 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N6953c5ac457342238a6c390b373f81c7
4 schema:citation sg:pub.10.1038/bcj.2015.60
5 sg:pub.10.1038/bcj.2016.89
6 sg:pub.10.1038/leu.2015.274
7 sg:pub.10.1038/nrdp.2017.46
8 sg:pub.10.1038/sj.leu.2404284
9 https://doi.org/10.1016/j.mayocp.2013.01.019
10 https://doi.org/10.1016/s0140-6736(10)61424-9
11 https://doi.org/10.1016/s0140-6736(16)31594-x
12 https://doi.org/10.1016/s0140-6736(18)33003-4
13 https://doi.org/10.1016/s1470-2045(14)71125-8
14 https://doi.org/10.1042/bsr20170304
15 https://doi.org/10.1046/j.1365-2141.1998.00930.x
16 https://doi.org/10.1056/nejmoa030288
17 https://doi.org/10.1056/nejmoa0801479
18 https://doi.org/10.1056/nejmoa1516282
19 https://doi.org/10.1056/nejmoa1611750
20 https://doi.org/10.1111/bjh.14733
21 https://doi.org/10.1182/blood-2007-05-090258
22 https://doi.org/10.1182/blood-2010-02-268862
23 https://doi.org/10.1182/blood-2011-08-373514
24 https://doi.org/10.1182/blood-2011-11-374249
25 https://doi.org/10.1182/blood-2011-11-395749
26 https://doi.org/10.1182/blood-2012-04-403733
27 https://doi.org/10.1182/blood-2012-08-448563
28 https://doi.org/10.1182/blood-2012-11-464503
29 https://doi.org/10.1182/blood-2014-01-548826
30 https://doi.org/10.1182/blood-2014-01-548941
31 https://doi.org/10.1182/blood-2016-05-717769
32 https://doi.org/10.1182/blood-2017-06-791228
33 https://doi.org/10.1182/blood-2017-07-795047
34 https://doi.org/10.1200/jco.2011.39.6820
35 https://doi.org/10.1200/jco.2012.48.4626
36 https://doi.org/10.1200/jco.2014.58.7618
37 https://doi.org/10.1200/jco.2014.60.2466
38 https://doi.org/10.1586/17474086.2015.1001360
39 https://doi.org/10.2147/jbm.s102328
40 https://doi.org/10.3324/haematol.2017.170118
41 schema:datePublished 2019-01-29
42 schema:datePublishedReg 2019-01-29
43 schema:description Triplet combinations containing a proteasome inhibitor are a standard of care in newly diagnosed multiple myeloma (NDMM). We examined the long-term efficacy and safety of the all-oral combination of weekly ixazomib plus lenalidomide-dexamethasone (IRd), followed by single-agent ixazomib maintenance in NDMM patients. Of 65 enrolled patients, 53 received ixazomib 4 mg (days 1, 8, and 15) plus lenalidomide 25 mg (days 1-21) and dexamethasone 40 mg (days 1, 8, 15, and 22) for up to twelve 28-day induction cycles. Twenty-three patients discontinued induction for stem cell transplantation (SCT). In the remaining 42 patients, overall response rate was 80%, including 63% ≥very good partial response (VGPR) and 32% complete responses. At a median follow-up of 56 months, median progression-free survival (PFS) was 35.4 months in the total population. Twenty-five patients received ixazomib maintenance; eight deepened their response (76% ≥VGPR), and median PFS was 37.2 months in this subgroup. Nine of 42 patients who did not proceed to SCT (14% of total population) had an adverse event requiring discontinuation. Ixazomib (median ≥ 96%) and lenalidomide (median 88-94%) relative dose intensities were maintained throughout treatment. Weekly IRd, followed by ixazomib maintenance, was highly active with acceptable toxicity, enabling long-term administration with no evidence of cumulative toxicities.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree false
47 schema:isPartOf sg:journal.1097065
48 schema:name Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance
49 schema:pagination 1-11
50 schema:productId N3c3a7546fcfe4c81a98db83b325254ab
51 N4b197ed18156456a93fb1b4eb153933e
52 N538565acd1114f279bc8d3af68f17fca
53 N798435b7088a4f889673fa79c5549820
54 N95f334188504458b957f0c594dd4985c
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111760610
56 https://doi.org/10.1038/s41375-019-0384-1
57 schema:sdDatePublished 2019-04-11T08:58
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N36f5fac797b342ae956e7d06c92a3878
60 schema:url https://www.nature.com/articles/s41375-019-0384-1
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N0e33a98d77144818b8326822cdec0c2f schema:affiliation https://www.grid.ac/institutes/grid.189967.8
65 schema:familyName Kaufman
66 schema:givenName Jonathan L.
67 rdf:type schema:Person
68 N0f393507f52f40eda030b6f9bc6e9fc4 rdf:first N0e33a98d77144818b8326822cdec0c2f
69 rdf:rest N8d20f4ea2cf0404d82d704ba45c1e993
70 N1910fa961e264ae4a723d91d66d6e497 rdf:first Nbe56a4bd612b4580b35ff646b9f89904
71 rdf:rest Nd741c19d6e7247cf9887ccc47daa527a
72 N2384496abb2145d59bc29b45546901d3 schema:affiliation https://www.grid.ac/institutes/grid.417468.8
73 schema:familyName Stewart
74 schema:givenName A. Keith
75 rdf:type schema:Person
76 N2e96f1d318604f13bb062c28f2deea93 schema:affiliation https://www.grid.ac/institutes/grid.66875.3a
77 schema:familyName Rajkumar
78 schema:givenName S. Vincent
79 rdf:type schema:Person
80 N36880273d6644250b075b3d021cc37ea schema:name Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA
81 rdf:type schema:Organization
82 N36f5fac797b342ae956e7d06c92a3878 schema:name Springer Nature - SN SciGraph project
83 rdf:type schema:Organization
84 N3c3a7546fcfe4c81a98db83b325254ab schema:name doi
85 schema:value 10.1038/s41375-019-0384-1
86 rdf:type schema:PropertyValue
87 N4b197ed18156456a93fb1b4eb153933e schema:name nlm_unique_id
88 schema:value 8704895
89 rdf:type schema:PropertyValue
90 N4d531ce8a1d84bb493e4101aff3e8b3e rdf:first N6210456c9e8e465d9bcee085e896eb28
91 rdf:rest N9cdccb233ed0453f82994368002541bb
92 N538565acd1114f279bc8d3af68f17fca schema:name readcube_id
93 schema:value 17f8a23583019643f4f75c37daa9c14411e4b50d70ed085e760755064ba59018
94 rdf:type schema:PropertyValue
95 N5a53d9dbfb3b4ea98c99dcb26cb91491 rdf:first N819eb34765ae4e81aee619bc2fbc5cfc
96 rdf:rest Nf334890f5ee84f07ae034f5bd62fc85e
97 N5bcd8ccf8ca24d5cb17cf674a4563457 rdf:first N80a101dbabce42b5b3d54cbf785be05b
98 rdf:rest Nb750b65cdaed47ccb929ad80ed94e585
99 N6210456c9e8e465d9bcee085e896eb28 schema:affiliation https://www.grid.ac/institutes/grid.419513.b
100 schema:familyName Berdeja
101 schema:givenName Jesus G.
102 rdf:type schema:Person
103 N63b07d0c7f1347d4a7a00fd326f8fbcb rdf:first Nb711e8641c6a4ef98b90d830d16c4989
104 rdf:rest rdf:nil
105 N65a6008a38764a429dd5375f416a7d2f rdf:first N96df330a3afa4427935dbec3c430ba41
106 rdf:rest N0f393507f52f40eda030b6f9bc6e9fc4
107 N6953c5ac457342238a6c390b373f81c7 rdf:first Nc5afc0042fc44b19aeabcd1ea53e20f5
108 rdf:rest N4d531ce8a1d84bb493e4101aff3e8b3e
109 N798435b7088a4f889673fa79c5549820 schema:name dimensions_id
110 schema:value pub.1111760610
111 rdf:type schema:PropertyValue
112 N80a101dbabce42b5b3d54cbf785be05b schema:affiliation https://www.grid.ac/institutes/grid.268154.c
113 schema:familyName Hamadani
114 schema:givenName Mehdi
115 rdf:type schema:Person
116 N819eb34765ae4e81aee619bc2fbc5cfc schema:affiliation https://www.grid.ac/institutes/grid.189967.8
117 schema:familyName Lonial
118 schema:givenName Sagar
119 rdf:type schema:Person
120 N8d20f4ea2cf0404d82d704ba45c1e993 rdf:first Ned96cbeb93264ab28a03bae08c1f2a96
121 rdf:rest N1910fa961e264ae4a723d91d66d6e497
122 N95f334188504458b957f0c594dd4985c schema:name pubmed_id
123 schema:value 30696949
124 rdf:type schema:PropertyValue
125 N96df330a3afa4427935dbec3c430ba41 schema:affiliation N36880273d6644250b075b3d021cc37ea
126 schema:familyName Vescio
127 schema:givenName Robert
128 rdf:type schema:Person
129 N9b5922897df64a9a9c23d4884eb6d3bb schema:affiliation https://www.grid.ac/institutes/grid.30760.32
130 schema:familyName Hari
131 schema:givenName Parameswaran
132 rdf:type schema:Person
133 N9cdccb233ed0453f82994368002541bb rdf:first Ne91c2f4e8c8d4aebbbc161140b490104
134 rdf:rest N5a53d9dbfb3b4ea98c99dcb26cb91491
135 Nb711e8641c6a4ef98b90d830d16c4989 schema:affiliation https://www.grid.ac/institutes/grid.65499.37
136 schema:familyName Richardson
137 schema:givenName Paul G.
138 rdf:type schema:Person
139 Nb750b65cdaed47ccb929ad80ed94e585 rdf:first N2384496abb2145d59bc29b45546901d3
140 rdf:rest Ne31fa39facf74ef791eb78255a2f7c28
141 Nbe56a4bd612b4580b35ff646b9f89904 schema:affiliation https://www.grid.ac/institutes/grid.417832.b
142 schema:familyName Liao
143 schema:givenName Eileen
144 rdf:type schema:Person
145 Nc5afc0042fc44b19aeabcd1ea53e20f5 schema:affiliation https://www.grid.ac/institutes/grid.66875.3a
146 schema:familyName Kumar
147 schema:givenName Shaji K.
148 rdf:type schema:Person
149 Nd741c19d6e7247cf9887ccc47daa527a rdf:first N2e96f1d318604f13bb062c28f2deea93
150 rdf:rest N63b07d0c7f1347d4a7a00fd326f8fbcb
151 Ne2dbccac90c54d07a047b0efba14c6b7 schema:affiliation https://www.grid.ac/institutes/grid.417467.7
152 schema:familyName Roy
153 schema:givenName Vivek
154 rdf:type schema:Person
155 Ne31fa39facf74ef791eb78255a2f7c28 rdf:first N9b5922897df64a9a9c23d4884eb6d3bb
156 rdf:rest Nf984aae6046442f39d1f776ce3260c71
157 Ne91c2f4e8c8d4aebbbc161140b490104 schema:affiliation https://www.grid.ac/institutes/grid.413734.6
158 schema:familyName Niesvizky
159 schema:givenName Ruben
160 rdf:type schema:Person
161 Ned96cbeb93264ab28a03bae08c1f2a96 schema:affiliation https://www.grid.ac/institutes/grid.419849.9
162 schema:familyName Berg
163 schema:givenName Deborah
164 rdf:type schema:Person
165 Nee2526da792443cca04ef992e842687f schema:affiliation https://www.grid.ac/institutes/grid.65499.37
166 schema:familyName Laubach
167 schema:givenName Jacob P.
168 rdf:type schema:Person
169 Nf334890f5ee84f07ae034f5bd62fc85e rdf:first Nee2526da792443cca04ef992e842687f
170 rdf:rest N5bcd8ccf8ca24d5cb17cf674a4563457
171 Nf984aae6046442f39d1f776ce3260c71 rdf:first Ne2dbccac90c54d07a047b0efba14c6b7
172 rdf:rest N65a6008a38764a429dd5375f416a7d2f
173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical and Health Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
177 schema:name Oncology and Carcinogenesis
178 rdf:type schema:DefinedTerm
179 sg:journal.1097065 schema:issn 0887-6924
180 1476-5551
181 schema:name Leukemia
182 rdf:type schema:Periodical
183 sg:pub.10.1038/bcj.2015.60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016382579
184 https://doi.org/10.1038/bcj.2015.60
185 rdf:type schema:CreativeWork
186 sg:pub.10.1038/bcj.2016.89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033740632
187 https://doi.org/10.1038/bcj.2016.89
188 rdf:type schema:CreativeWork
189 sg:pub.10.1038/leu.2015.274 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044481919
190 https://doi.org/10.1038/leu.2015.274
191 rdf:type schema:CreativeWork
192 sg:pub.10.1038/nrdp.2017.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090829304
193 https://doi.org/10.1038/nrdp.2017.46
194 rdf:type schema:CreativeWork
195 sg:pub.10.1038/sj.leu.2404284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033553106
196 https://doi.org/10.1038/sj.leu.2404284
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/j.mayocp.2013.01.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023181533
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/s0140-6736(10)61424-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008465800
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/s0140-6736(16)31594-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1003452470
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/s0140-6736(18)33003-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110509482
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/s1470-2045(14)71125-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012022447
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1042/bsr20170304 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090694444
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1046/j.1365-2141.1998.00930.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051933965
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1056/nejmoa030288 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028177288
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1056/nejmoa0801479 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043382081
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1056/nejmoa1516282 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035239228
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1056/nejmoa1611750 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084540242
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1111/bjh.14733 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085218183
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1182/blood-2007-05-090258 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012727802
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1182/blood-2010-02-268862 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023108271
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1182/blood-2011-08-373514 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026926325
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1182/blood-2011-11-374249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040451549
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1182/blood-2011-11-395749 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014156690
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1182/blood-2012-04-403733 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034167280
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1182/blood-2012-08-448563 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027118737
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1182/blood-2012-11-464503 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019804798
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1182/blood-2014-01-548826 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039247879
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1182/blood-2014-01-548941 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037215825
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1182/blood-2016-05-717769 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064123122
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1182/blood-2017-06-791228 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092354997
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1182/blood-2017-07-795047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092754671
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1200/jco.2011.39.6820 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029641259
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1200/jco.2012.48.4626 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017077030
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1200/jco.2014.58.7618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035321177
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1200/jco.2014.60.2466 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045415758
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1586/17474086.2015.1001360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045860916
257 rdf:type schema:CreativeWork
258 https://doi.org/10.2147/jbm.s102328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091307845
259 rdf:type schema:CreativeWork
260 https://doi.org/10.3324/haematol.2017.170118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090917868
261 rdf:type schema:CreativeWork
262 https://www.grid.ac/institutes/grid.189967.8 schema:alternateName Emory University
263 schema:name Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA
264 rdf:type schema:Organization
265 https://www.grid.ac/institutes/grid.268154.c schema:alternateName West Virginia University
266 schema:name West Virginia University, Mary Babb Randolph Cancer Center, Morgantown, WV, USA
267 rdf:type schema:Organization
268 https://www.grid.ac/institutes/grid.30760.32 schema:alternateName Medical College of Wisconsin
269 schema:name Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
270 rdf:type schema:Organization
271 https://www.grid.ac/institutes/grid.413734.6 schema:alternateName NewYork–Presbyterian Hospital
272 schema:name Myeloma Center, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA
273 rdf:type schema:Organization
274 https://www.grid.ac/institutes/grid.417467.7 schema:alternateName Mayo Clinic
275 schema:name Mayo Clinic, Jacksonville, FL, USA
276 rdf:type schema:Organization
277 https://www.grid.ac/institutes/grid.417468.8 schema:alternateName Mayo Clinic
278 schema:name Mayo Clinic College of Medicine, Scottsdale, AZ, USA
279 rdf:type schema:Organization
280 https://www.grid.ac/institutes/grid.417832.b schema:alternateName Biogen (United States)
281 schema:name Biogen Inc., Cambridge, MA, USA
282 Millennium Pharmaceuticals Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA
283 rdf:type schema:Organization
284 https://www.grid.ac/institutes/grid.419513.b schema:alternateName Sarah Cannon
285 schema:name Sarah Cannon Research Institute, Nashville, TN, USA
286 rdf:type schema:Organization
287 https://www.grid.ac/institutes/grid.419849.9 schema:alternateName Takeda (United States)
288 schema:name Millennium Pharmaceuticals Inc. (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA
289 rdf:type schema:Organization
290 https://www.grid.ac/institutes/grid.65499.37 schema:alternateName Dana–Farber Cancer Institute
291 schema:name Dana-Farber Cancer Institute, Boston, MA, USA
292 rdf:type schema:Organization
293 https://www.grid.ac/institutes/grid.66875.3a schema:alternateName Mayo Clinic
294 schema:name Mayo Clinic, Rochester, MN, USA
295 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...